Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial

PURPOSE: Intratumoral hypoxia increases resistance of head-and-neck squamous cell carcinoma (HNSCC) to radiotherapy. [(18)F]FMISO PET imaging enables noninvasive hypoxia monitoring, though requiring complex logistical efforts. We investigated the role of plasma interleukin-6 (IL-6) as potential surr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Wiedenmann, Nicole, Fennell, Jamina T., Mix, Michael, Ruf, Juri, Stoian, Raluca, Thomsen, Andreas R., Vaupel, Peter, Baltas, Dimos, Grosu, Anca-L., Nicolay, Nils H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940848/
https://www.ncbi.nlm.nih.gov/pubmed/34773163
http://dx.doi.org/10.1007/s00259-021-05602-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940848/
https://www.ncbi.nlm.nih.gov/pubmed/34773163
http://dx.doi.org/10.1007/s00259-021-05602-x

Ejemplares similares